Ellagica acid inhibits arylamine N-acetyltransferase activity and DNA adduct formation in human bladder tumor cell lines (T24 and TSGH 8301) S. LinC. HungJ. Chung Original Paper 05 February 2014 Pages: 371 - 376
The genetic alterations in the oncogenic pathway of transitional cell carcinoma of the bladder and its prognostic value Paolo GonteroAlessandro TizzaniMichele Pavone Macaluso Original Paper 05 February 2014 Pages: 377 - 387
Identification and functional study of phosphodiesterases in rat urinary bladder Yuhong QiuPatricia KraftDonna Haynes-Johnson Original Paper 05 February 2014 Pages: 388 - 392
p53 codon 72 polymorphism in bladder cancer – no evidence of association with increased risk or invasiveness Gökçe A. TörünerAhmet UçarTayfun Özçelik Original Paper 05 February 2014 Pages: 393 - 395
Photodynamic therapy in superficial bladder cancer: past, present and future Patrice JichlinskiHans-Jürg Leisinger Invited Editorial 05 February 2014 Pages: 396 - 405
Sulindac inhibited gene expression and activity of arylamine N-acetyltransferase and DNA-2-aminofluorene adduct formation in T24 human bladder tumor cells C. YangJ. Chung Original Paper 05 February 2014 Pages: 406 - 411
Lack of evidence for the association of tumor necrosis factor-alpha gene promoter polymorphism with calcium oxalate stone and bladder cancer patients Fuu-Jen TsaiHsueh-Fu LuWen-Chi Chen Original Paper 05 February 2014 Pages: 412 - 416
Hydroxyapatite induction and secondary aggregation of calcium oxalate, two important processes in calcium stone formation J. BaumannB. AffolterF. Maier Original Paper 05 February 2014 Pages: 417 - 422
Differential involvement of reactive oxygen species and myeloperoxidase in oxygen-dependent killing of urinary tract bacterial isolates by polymorphonuclear leukocytes Hitoshi Oh-okaMasato FujisawaSadao Kamidono Original Paper 05 February 2014 Pages: 423 - 427
2002 30th Munich Endourological Symposium 10–11 October 2002 Announcements 05 February 2014 Pages: 428 - 428
